GlassScriptPhysician profile
Arth M Patel
NPI 1992117162
$1,707.10
in general payments reported to CMS, 2019-2025
19 companies · $153 in 2025
The $153 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $234 · 2021: $28.37 · 2022: $229 · 2023: $372 · 2024: $92.96 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $578.52 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $215.27 | 2019-2023 | Cequa |
| Boston Scientific Corporation | $168.02 | 2022-2023 | Wavewriter Alpha Prime 16 |
| Ferring Pharmaceuticals INC. | $109.93 | 2020-2023 | Euflexxa |
| Depuy Synthes Sales INC. | $104.62 | 2019-2024 | Monovisc, Orthovisc |
| Ibsa Pharma INC. | $103.41 | 2022-2023 | Tirosint, Licart |
| Horizon Therapeutics Plc | $85.01 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $50.69 | 2024-2025 | Belbuca |
| Orthofix Medical, INC. | $45.42 | 2019 | |
| Stryker Corporation | $44.22 | 2024 | Motionsense Digital Goniometer |
| Zimmer Biomet Holdings, INC. | $42.66 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Averitas Pharma INC. | $37.50 | 2025 | Qutenza |
| Seapearl East, INC | $19.82 | 2025 | |
| Epimed International, INC | $19.24 | 2024 | Prp |
| Vertex Pharmaceuticals Incorporated | $18.64 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.50 | 2019 | |
| Nevro Corp. | $16.51 | 2023 | Senza |
| Fidia Pharma USA INC. | $16.26 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.